| Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ... Cell 183 (4), 1024-1042. e21, 2020 | 1274 | 2020 |
| Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 1100 | 2022 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 557 | 2021 |
| Broad betacoronavirus neutralization by a stem helix–specific human antibody D Pinto, MM Sauer, N Czudnochowski, JS Low, MA Tortorici, MP Housley, ... Science 373 (6559), 1109-1116, 2021 | 277 | 2021 |
| Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality C Di Lorenzo, A Ceschi, H Kupferschmidt, S Lüde, ... British journal of clinical pharmacology 79 (4), 578-592, 2015 | 180 | 2015 |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages YJ Park, D Pinto, AC Walls, Z Liu, A De Marco, F Benigni, F Zatta, ... Science 378 (6620), 619-627, 2022 | 150 | 2022 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 JS Low, D Vaqueirinho, F Mele, M Foglierini, J Jerak, M Perotti, ... Science 372 (6548), 1336-1341, 2021 | 124 | 2021 |
| Mushroom poisoning: a study on circumstances of exposure and patterns of toxicity KM Schenk-Jaeger, C Rauber-Lüthy, M Bodmer, H Kupferschmidt, ... European journal of internal medicine 23 (4), e85-e91, 2012 | 123 | 2012 |
| The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... BioRxiv, 2020.11. 04.355842, 2020 | 108 | 2020 |
| Immune checkpoint inhibitor-related cytokine release syndrome: analysis of WHO global pharmacovigilance database A Ceschi, R Noseda, K Palin, K Verhamme Frontiers in pharmacology 11, 529822, 2020 | 105 | 2020 |
| Ketamine-like effects after recreational use of methoxetamine KE Hofer, B Grager, DM Müller, C Rauber-Lüthy, H Kupferschmidt, ... Annals of emergency medicine 60 (1), 97-99, 2012 | 102 | 2012 |
| ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... Science 377 (6607), 735-742, 2022 | 91 | 2022 |
| Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland L Piccoli, P Ferrari, G Piumatti, S Jovic, BF Rodriguez, F Mele, ... The Lancet Regional Health–Europe 1, 2021 | 83 | 2021 |
| Acute plant poisoning: analysis of clinical features and circumstances of exposure J Fuchs, C Rauber-Lüthy, H Kupferschmidt, J Kupper, GA Kullak-Ublick, ... Clinical toxicology 49 (7), 671-680, 2011 | 78 | 2011 |
| A two year study of verified spider bites in Switzerland and a review of the European spider bite literature W Nentwig, M Gnädinger, J Fuchs, A Ceschi Toxicon 73, 104-110, 2013 | 72 | 2013 |
| Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports R Noseda, R Bertoli, L Müller, A Ceschi Journal for immunotherapy of cancer 7, 1-6, 2019 | 66 | 2019 |
| Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center C Reichert, P Reichert, F Monnet-Tschudi, H Kupferschmidt, A Ceschi, ... Clinical toxicology 52 (6), 629-634, 2014 | 60 | 2014 |
| Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database R Noseda, F Bedussi, C Gobbi, C Zecca, A Ceschi Cephalalgia 41 (7), 789-798, 2021 | 53 | 2021 |
| Adverse effects of plant food supplements self-reported by consumers in the PlantLIBRA survey involving six European countries P Restani, C Di Lorenzo, A Garcia-Alvarez, M Badea, A Ceschi, B Egan, ... PLoS One 11 (2), e0150089, 2016 | 52 | 2016 |
